6-Keto-PGE.sub.1 amides
    3.
    发明授权
    6-Keto-PGE.sub.1 amides 失效
    6-Keto-PGE1酰胺

    公开(公告)号:US4246197A

    公开(公告)日:1981-01-20

    申请号:US70225

    申请日:1979-08-27

    申请人: Udo F. Axen

    发明人: Udo F. Axen

    IPC分类号: C07C405/00 C07C103/19

    CPC分类号: C07C405/00

    摘要: Prostaglandin E (PGE)-type derivatives and analogs having a 6-keto feature are disclosed, including processes for preparing them and the appropriate intermediates, said derivatives having pharmacological activity.

    摘要翻译: 公开了具有6-酮特征的前列腺素E(PGE)型衍生物和类似物,包括制备它们的方法和适当的中间体,所述衍生物具有药理活性。

    6-Keto-.omega.aryl-PGE.sub.1 compounds
    4.
    发明授权
    6-Keto-.omega.aryl-PGE.sub.1 compounds 失效
    6-酮-ω-芳基-PGEE化合物

    公开(公告)号:US4223157A

    公开(公告)日:1980-09-16

    申请号:US70228

    申请日:1979-08-27

    申请人: Udo F. Axen

    发明人: Udo F. Axen

    IPC分类号: C07C405/00 C07C177/00

    CPC分类号: C07C405/00

    摘要: Prostaglandin E (PGE)-type derivatives and analogs having a 6-ketone feature are disclosed, including processes for preparing them and the appropriate intermediates, said derivatives having pharmacological activity.

    摘要翻译: 公开了具有6-酮特征的前列腺素E(PGE)型衍生物和类似物,包括其制备方法和合适的中间体,所述衍生物具有药理活性。

    2,2-Difluoro-PGF.sub.2 analogs
    5.
    发明授权
    2,2-Difluoro-PGF.sub.2 analogs 失效
    2,2-二氟-PGF2类似物

    公开(公告)号:US4209637A

    公开(公告)日:1980-06-24

    申请号:US724110

    申请日:1976-09-17

    申请人: Udo F. Axen

    发明人: Udo F. Axen

    摘要: 2,2-Difluoro prostaglandin E, F.sub..alpha., F.sub..beta., A, and B analogs are disclosed with intermediates and with processes for making them. These compounds differ from the prostaglandins in that they have two fluoro atoms at the C-2 position in place of the two hydrogen atoms at C-2 in the prostaglandins. These compounds are useful for a variety of pharmacological purposes, including antiulcer, inhibition of platelet aggregation, increase in nasal patency, labor induction at term, and wound healing.

    摘要翻译: 2,2-二氟前列腺素E,Fα,Fβ,A和B类似物与中间体及其制备方法一起公开。 这些化合物不同于前列腺素,因为它们在C-2位置具有两个氟原子代替前列腺素中C-2处的两个氢原子。 这些化合物可用于各种药理目的,包括抗溃疡,抑制血小板聚集,增加鼻通气,术中劳动诱导和伤口愈合。

    6-Keto PGF analogs
    6.
    发明授权
    6-Keto PGF analogs 失效
    6-Keto PGF类似物

    公开(公告)号:US4158667A

    公开(公告)日:1979-06-19

    申请号:US819857

    申请日:1977-07-28

    申请人: Udo F. Axen

    发明人: Udo F. Axen

    摘要: Prostaglandin (PG.sub.1) derivatives having (1) a 6-keto feature, for example ##STR1## or (2) a 9-deoxy-6,9-epoxy feature together with a 5-halo or 6-hydroxy feature, for example ##STR2## said derivatives having pharmacological activity. Processes for preparing them and the appropriate intermediates are disclosed.

    摘要翻译: 具有(1)6-酮特征的前列腺素(PG1)衍生物,例如具有5-卤素或6-羟基特征的例如或(2)9-脱氧-6,9-环氧特征, IMAGE>或表示具有药理活性的衍生物。 公开了制备它们的方法和合适的中间体。

    2-Decarboxy-2-aminomethyl-6-keto-PG compounds
    10.
    发明授权
    2-Decarboxy-2-aminomethyl-6-keto-PG compounds 失效
    2-脱羧基-2-氨基甲基-6-酮基-PG化合物

    公开(公告)号:US4236025A

    公开(公告)日:1980-11-25

    申请号:US85833

    申请日:1979-10-17

    申请人: Udo F. Axen

    发明人: Udo F. Axen

    IPC分类号: C07C405/00 C07C177/00

    CPC分类号: C07C405/0041 C07C405/00

    摘要: The present invention relates to novel 2-decarboxy-2-aminomethyl-6-keto-PG compounds, which are useful for inducing a variety of prostacyclin-like pharmacological effects. Accordingly, these compounds are useful pharmacological agents for the same purposes for which prostacyclin is employed.

    摘要翻译: 本发明涉及新的2-脱羧基-2-氨基甲基-6-酮基-PG化合物,其可用于诱导各种前列环素样药理作用。 因此,这些化合物是用于前列环素用于相同目的的有用的药理学试剂。